DOI: 10.1128/AAC.01545-16
Article Information
PubMed
Published By
History
- Received July 15, 2016
- Returned for modification August 1, 2016
- Accepted August 28, 2016
- Published online October 21, 2016.
Copyright & Usage
Copyright © 2016, American Society for Microbiology. All Rights Reserved.
Article Versions
- Accepted Manuscript version (September 06, 2016).
- You are viewing the most recent version of this article.
Author Information
- Valter Viana Andrade-Netoa,
- Edézio Ferreira Cunha-Júniora,
- Marilene Marcuzzo do Canto-Cavalheiroa,
- Geórgia Correa Atellab,
- Talita de Almeida Fernandesc,
- Paulo Roberto Ribeiro Costac and
- Eduardo Caio Torres-Santosa
- aLaboratório de Bioquímica de Tripanosomatídeos, Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, Brazil
- bInstituto de Bioquímica Médica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
- cLaboratório de Química Bioorgânica, Instituto de Pesquisas de Produtos Naturais, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
- Address correspondence to Eduardo Caio Torres-Santos, ects{at}ioc.fiocruz.br.
Citation Andrade-Neto VV, Cunha-Júnior EF, Canto-Cavalheiro MMD, Atella GC, Fernandes TDA, Costa PRR, Torres-Santos EC. 2016. Antileishmanial activity of ezetimibe: inhibition of sterol biosynthesis, in vitro synergy with azoles, and efficacy in experimental cutaneous leishmaniasis. Antimicrob Agents Chemother 60:6844–6852. doi:10.1128/AAC.01545-16.
